Oxygen tension plays a critical role in the hematopoietic microenvironment in vitro

Haematologica

Volumn 97, Issue 3, 2012, Pages 331-339

  Jing, Duohui ^a   Wobus, Manja ^a   Poitz, David M ^b   Bornhäuser, Martin ^a   Ehninger, Gerhard ^a   Ordemann, Rainer ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

C34 + cells; Hematopoietic microenvironment; Mesenchymal stromal cells; Oxygen tension

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; OXYGEN; PIMONIDAZOLE; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; CD34 SELECTION; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STROMA CELL; NORMAL HUMAN; OXYGEN TENSION; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL NICHE; TUMOR MICROENVIRONMENT;

ANOXIA; ANTIGENS, CD34; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL ADHESION; CELL MOVEMENT; CHEMOKINE CXCL12; COCULTURE TECHNIQUES; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOPHENOTYPING; INTEGRINS; MESENCHYMAL STROMAL CELLS; OXYGEN; PROTEIN BINDING; RECEPTORS, CXCR4; STEM CELL NICHE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857707368     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.050815     Document Type: Article

References (43)

1. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):193-7.
2. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science. 2002;297(5590):2256-9.
3. Metcalf D. On hematopoietic stem cell fate. Immunity. 2007;26(6):669-73.
4. Thomas ED. Landmarks in the development of hematopoietic cell transplantation. World J Surg. 2000;24(7):815-8.
5. Bornhauser M, Eger L, Oelschlaegel U, Uffermann-Gretzinger S, Kiani A, Schetelig J, et al. Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells. Leukemia. 2005;19(1):161-5.
6. Sorrentino BP. Clinical strategies for expansion of haematopoietic stem cells. Nat Rev Immunol. 2004;4(11):878-88.
7. Heike T, Nakahata T. Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim Biophys Acta. 2002;1592(3):313-21.
8. Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105(7):1013-21.
9. Burger JA, Spoo A, Dwenger A, Burger M, Behringer D. CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis). Br J Haematol. 2003; 122(4):579-89.
10. Freund D, Bauer N, Boxberger S, Feldmann S, Streller U, Ehninger G, et al. Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity. Stem Cells Dev. 2006;15(6): 815-29.
11. Gottschling S, Saffrich R, Seckinger A, Krause U, Horsch K, Miesala K, et al. Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrindependent mechanism. Stem Cells. 2007; 25(3):798-806.
12. Wagner W, Roderburg C, Wein F, Diehlmann A, Frankhauser M, Schubert R, et al. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells. 2007;25(10):2638-47.
13. Alakel N, Jing D, Muller K, Bornhauser M, Ehninger G, Ordemann R. Direct contact with mesenchymal stromal cells affects migratory behavior and gene expression profile of CD133+ hematopoietic stem cells during ex vivo expansion. Exp Hematol. 2009;37(4):504-13.
14. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003;425(6960): 836-41.
15. Scadden DT. The stem-cell niche as an entity of action. Nature. 2006;441(7097):1075-9.
16. Yahata T, Muguruma Y, Yumino S, Sheng Y, Uno T, Matsuzawa H, et al. Quiescent human hematopoietic stem cells in the bone marrow niches organize the hierarchical structure of hematopoiesis. Stem Cells. 2008;26(12):3228-36
17. Dello SP, Cipolleschi MG, Olivotto M. Hemopoietic progenitor cells are sensitive to the cytostatic effect of pyruvate. Exp Hematol. 1987;15(2):137-42.
18. Harrison JS, Rameshwar P, Chang V, Bandari P. Oxygen saturation in the bone marrow of healthy volunteers. Blood. 2002;99(1):394.
19. Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA. 2007;104(13):5431-6.
20. Kubota Y, Takubo K, Suda T. Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche. Biochem Biophys Res Commun. 2008;366(2):335-9.
21. Ivanovic Z, Hermitte F, Brunet de la GP, Dazey B, Belloc F, Lacombe F, et al. Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%). Stem Cells. 2004;22 (5):716-24.
22. Shima H, Takubo K, Iwasaki H, Yoshihara H, Gomei Y, Hosokawa K, et al. Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice. Biochem Biophys Res Commun. 2009;378(3):467-72.
23. Eliasson P, Rehn M, Hammar P, Larsson P, Sirenko O, Flippin LA, et al. Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Exp Hematol. 2010;38(4):301-10.
24. Jing D, Fonseca AV, Alakel N, Fierro FA, Muller K, Bornhauser M, et al. Hematopoietic stem cells in coculture with mesenchymal stromal cells-modelling the niche compartments in vitro. Haematologica. 2010;95(4):542-50.
25. Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004;22(3):377-84.
26. Maemura K, Hsieh CM, Jain MK, Fukumoto S, Layne MD, Liu Y, et al. Generation of a dominant-negative mutant of endothelial PAS domain protein 1 by deletion of a potent C-terminal transactivation domain. J Biol Chem. 1999;274(44):31565-70.
27. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106(6):1901-10.
28. Prager GW, Lackner EM, Krauth MT, Unseld M, Poettler M, Laffer S, et al. Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab. Mol Oncol. 2010;4(2): 150-60.
29. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2006;6(2):93-106.
30. Ivanovic Z. Hypoxia or in situ normoxia: The stem cell paradigm. J Cell Physiol. 2009;219(2):271-5.
31. Simsek T, Kocabas F, Zheng J, DeBerardinis RJ, Mahmoud AI, Olson EN, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010;7(3):380-90.
32. Dos SF, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol. 2010;223(1):27-35.
33. Das R, Jahr H, van OG, Farrell E. The role of hypoxia in MSCs: considerations for regenerative medicine approaches. Tissue Eng Part B Rev. 2010;16(2):159-68.
34. Levesque JP, Winkler IG, Hendy J, Williams B, Helwani F, Barbier V, et al. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells. 2007;25(8):1954-65.
35. Ohnishi S, Yasuda T, Kitamura S, Nagaya N. Effect of hypoxia on gene expression of bone marrow-derived mesenchymal stem cells and mononuclear cells. Stem Cells. 2007;25(5):1166-77.
36. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004;35(3):233-45.
37. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10(8):858-64.
38. Ceradini DJ, Gurtner GC. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med. 2005;15(2):57-63.
39. Robinson S, Niu T, de LM, Ng J, Yang H, McMannis J, et al. Ex vivo expansion of umbilical cord blood. Cytotherapy. 2005;7(3):243-50.
40. Elvidge GP, Glenny L, Appelhoff RJ, Ratcliffe PJ, Ragoussis J, Gleadle JM. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem. 2006;281(22):15215-26.
41. Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B, et al. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors. Leukemia. 2009;23(1):162-9.
42. Semenza G. Signal transduction to hypoxiainducible factor 1. Biochem Pharmacol. 2002;64(5-6):993-8.
43. Lerman OZ, Greives MR, Singh SP, Thanik VD, Chang CC, Seiser N, et al. Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and-independent SDF-1 induction. Blood. 2010;116(18):3669-76.